Abiopharma

🔍 L1 Capital Pty Ltd (Executive)

Company: Anteris Technologies Global Corp. (AVR)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Sold 251,844 shares of Common Stock at $9.1 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,187,156.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 375,815 shares of Common Stock at $9.3 per share (Direct)
  Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,811,341.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 5,359,470 shares of CHESS Depository Interests (Derivative)
  Date: 2026-08-10 | Code: H | shares_owned_after: 5,359,470.00 | Footnotes: F1, F3, F3, F4, F2
• Holds 1,333,334 shares of CHESS Depository Interest Warrants at $11.5 per share (Derivative)
  Date: 2026-08-10 | Code: H | Expires: 2030-10-30 | Exercise: 2026-05-01 | shares_owned_after: 1,333,334.00 | Footnotes: F1, F5, F7, F2

Footnotes:

• F1: In submitting this Form 4, the Reporting Person does not admit that it is obligated to file ownership reports under the Securities Exchange Act of 1934 since it is exempt under Rule 16a-2.
• F2: The shares are owned by the L1 Long Short Fund Limited, the L1 Capital Long Short Fund, and the L1 Capital Long Short (Master) Fund, all controlled and managed by L1 Capital Pty Ltd.
• F3: The CHESS Depository Interests represent one underlying share of the Issuers common stock and are exchangeable for shares of the Issuers common stock within 60 days.
• F4: Not applicable
• F5: Australian Dollars (AUD)
• F6: The CHESS Depository Interest Warrants represent one CHESS Depository Interest (which in turn represent one underlying share of the Issuers common stock) and are exercisable within 60 days subject to the exercise price and expiry date.
• F7: Subject to exercise price